FDA+ roundup: Number of drug surveillance inspections tripled from 2021 to 2022
Back in May 2020, thanks to the Covid pandemic, the FDA had to press pause on domestic and foreign routine surveillance inspections, which piled up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
